Australia markets closed

Biotron Limited (BIT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0810+0.0020 (+2.53%)
At close: 03:39PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 73.08M
Enterprise value 72.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.10k
Price/book (mrq)39.11
Enterprise value/revenue 358.89
Enterprise value/EBITDA -12.76

Trading information

Stock price history

Beta (5Y monthly) -0.60
52-week change 3200.00%
S&P500 52-week change 329.57%
52-week high 30.1250
52-week low 30.0240
50-day moving average 30.0846
200-day moving average 30.0700

Share statistics

Avg vol (3-month) 31.64M
Avg vol (10-day) 31.33M
Shares outstanding 5902.28M
Implied shares outstanding 6902.28M
Float 8728.15M
% held by insiders 119.75%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21.0413:1
Last split date 327 Mar 2006

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -244.54%
Operating margin (ttm)-83.40%

Management effectiveness

Return on assets (ttm)-56.72%
Return on equity (ttm)-103.96%

Income statement

Revenue (ttm)1.65M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)14.90%
Gross profit (ttm)N/A
EBITDA -4.16M
Net income avi to common (ttm)-4.02M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)721.68k
Total cash per share (mrq)0
Total debt (mrq)28.05k
Total debt/equity (mrq)1.50%
Current ratio (mrq)3.85
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-5.73M
Levered free cash flow (ttm)-4.31M